Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Statistics

Total Valuation

KYMR has a market cap or net worth of $2.63 billion. The enterprise value is $1.81 billion.

Market Cap	2.63B
Enterprise Value	1.81B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, before market open.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

KYMR has 64.77 million shares outstanding. The number of shares has increased by 19.60% in one year.

Current Share Class	64.77M
Shares Outstanding	64.77M
Shares Change (YoY)	+19.60%
Shares Change (QoQ)	+4.20%
Owned by Insiders (%)	1.29%
Owned by Institutions (%)	75.88%
Float	43.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.33
Forward PS	50.97
PB Ratio	2.95
P/TBV Ratio	2.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	20.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.55, with a Debt / Equity ratio of 0.10.

Current Ratio	8.55
Quick Ratio	8.29
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-806.89

Financial Efficiency

Return on equity (ROE) is -26.00% and return on invested capital (ROIC) is -16.75%.

Return on Equity (ROE)	-26.00%
Return on Assets (ROA)	-15.38%
Return on Capital (ROIC)	-16.75%
Revenue Per Employee	$468,251
Profits Per Employee	-$895,583
Employee Count	187
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +62.90% in the last 52 weeks. The beta is 2.17, so KYMR's price volatility has been higher than the market average.

Beta (5Y)	2.17
52-Week Price Change	+62.90%
50-Day Moving Average	45.95
200-Day Moving Average	41.32
Relative Strength Index (RSI)	40.14
Average Volume (20 Days)	532,546

Short Selling Information

The latest short interest is 9.02 million, so 13.92% of the outstanding shares have been sold short.

Short Interest	9.02M
Short Previous Month	9.12M
Short % of Shares Out	13.92%
Short % of Float	20.79%
Short Ratio (days to cover)	19.85

Income Statement

In the last 12 months, KYMR had revenue of $87.56 million and -$167.47 million in losses. Loss per share was -$2.41.

Revenue	87.56M
Gross Profit	-133.84M
Operating Income	-195.27M
Pretax Income	-157.85M
Net Income	-167.47M
EBITDA	-190.49M
EBIT	-195.27M
Loss Per Share	-$2.41

Balance Sheet

The company has $549.97 million in cash and $88.23 million in debt, giving a net cash position of $822.77 million or $12.70 per share.

Cash & Cash Equivalents	549.97M
Total Debt	88.23M
Net Cash	822.77M
Net Cash Per Share	$12.70
Equity (Book Value)	892.93M
Book Value Per Share	13.79
Working Capital	502.18M

Cash Flow

In the last 12 months, operating cash flow was -$124.67 million and capital expenditures -$23.53 million, giving a free cash flow of -$148.20 million.

Operating Cash Flow	-124.67M
Capital Expenditures	-23.53M
Free Cash Flow	-148.20M
FCF Per Share	-$2.29

Margins

Gross margin is -152.85%, with operating and profit margins of -223.00% and -191.26%.

Gross Margin	-152.85%
Operating Margin	-223.00%
Pretax Margin	-191.26%
Profit Margin	-191.26%
EBITDA Margin	-217.55%
EBIT Margin	-223.00%
FCF Margin	n/a

Dividends & Yields

KYMR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.60%
Shareholder Yield	-19.60%
Earnings Yield	-6.36%
FCF Yield	-5.63%

Analyst Forecast

The average price target for KYMR is $54.00, which is 32.81% higher than the current price. The consensus rating is "Buy".

Price Target	$54.00
Price Target Difference	32.81%
Analyst Consensus	Buy
Analyst Count	16
Revenue Growth Forecast (5Y)	37.07%
EPS Growth Forecast (5Y)	-14.08%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KYMR has an Altman Z-Score of 7.61 and a Piotroski F-Score of 4.

Altman Z-Score	7.61
Piotroski F-Score	4